Overexpression of Edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner

Clinical Cancer Research

Volumn 5, Issue 12, 1999, Pages 4308-4318

  Furui, Tatsuro ^a   LaPushin, Ruth ^a   Mao, Muling ^a   Khan, Humera ^a   Watt, Steve R ^a   Watt, Mary Ann V ^a   Lu, Yiling ^a   Fang, Xianjun ^a   Tsutsui, Shinichi ^a   Siddik, Zahid H ^a   Bast Jr , Robert C ^a   Mills, Gordon B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYSOPHOSPHATIDIC ACID;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INVASION; CANCER PATIENT; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; MEDIATOR RELEASE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIVISION; CISPLATIN; COS CELLS; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; JURKAT CELLS; LYSOPHOSPHOLIPIDS; MICE; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LYSOPHOSPHATIDIC ACID; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0033376891     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Moolenaar, W. H., Kranenburg, O., Postma, F. R., and Zondag, G. C. Lysophosphatidic acid: G-protein signaling and cellular responses. Curr. Opin. Cell Biol., 9: 168-173, 1997.
2. Hordijk, P. L., Verlaan, I., van Corven, E. J., and Moolenaar, W. H. Protein tyrosine phosphorylation induced by lysophosphatidic acid in Rat-1 fibroblasts: evidence that phosphorylation of map kinase is mediated by the Gi-p21ras pathway. J. Biol. Chem., 269: 645-651, 1994.
3. Mills, G. B., May, C., McGill, M., Roifman, C. M., and Mellors, A. A putative new growth factor in ascitic fluid from ovarian cancer patients: identification, characterization, and mechanism of action. Cancer Res., 48: 1066-1071, 1988.
4. Mills, G. B., May, C., Hill, M., Campbell, S., Shaw, P., and Marks, A. Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells. J. Clin. Investig., 86: 851-855, 1990.
5. Moolenaar, W. H., and van Corven, E. J. Growth factor-like action of lysophosphatidic acid: mitogenic signalling mediated by G proteins. Ciba Found. Symp., 150: 99-106, 1990.
6. Tigyi, G., Dyer, D. L., and Miledi, R. Lysophosphatidic acid possesses dual action in cell proliferation. Proc. Natl. Acad. Sci. USA, 91: 1908-1912, 1994.
7. van Corven, E. J., Groenink, A., Jalink, K., Eichholtz, T., and Moolenaar, W. H. Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell, 59: 45-54, 1989.
8. van Corven, E. J., van Rijswijk, A., Jalink, K., van der Bend, R. L., van Blitterswijk, W. J., and Moolenaar, W. H. Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts: dependence on acyl-chain length and inhibition by suramin. Biochem. J., 281: 163-169, 1992.
9. Xu, Y., Fang, X. J., Casey, G., and Mills, G. B. Lysophospholipids activate ovarian and breast cancer cells. Biochem. J., 309: 933-940, 1995.
10. Moolenaar, W. H. Lysophosphatidic acid, a multifunctional phospholipid messenger. J. Biol. Chem., 270: 12949-12952, 1995.
11. Jalink, K., Hordijk, P. L., and Moolenaar, W. H. Growth factor-like effects of lysophosphatidic acid, a novel lipid mediator. Biochim. Biophys. Acta, 1198: 185-196, 1994.
12. Yoshioka, K., Matsumura, F., Akedo, H., and Itoh, K. Small GTP-binding protein Rho stimulates the actomyosin system, leading to invasion of tumor cells. J. Biol. Chem., 273: 5146-5154, 1998.
13. Imamura, F., Horai, T., Mukai, M., Shinkai, K., Sawada, M., and Akedo, H. Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D. Biochem. Biophys. Res. Commun., 193: 497-503, 1993.
14. Stam, J. C., Michiels, F., Kammen, R. A., Moolenaar, W. H., and Collard, J. G. Invasion of T-lymphoma cells: cooperation between Rho family GTPases and lysophospholipid receptor signaling. EMBO J., 17: 4066-4074, 1998.
15. Holtsberg, F. W., Steiner, M. R., Keller, J. N., Mark, R. J., Mattson, M. P., and Steiner, S. M. Lysophosphatidic acid induces necrosis and apoptosis in hippocampal neurons. J. Neurochem., 70: 66-76, 1998.
16. Koh, J. S., Lieberthal, W., Heydrick, S., and Levine, J. S. Lysophosphatidic acid is a major serum noncytokine survival factor for murine macrophages which acts via the phosphatidylinositol 3-kinase signaling pathway. J. Clin. Investig., 102: 716-727, 1998.
17. Levine, J. S., Koh, J. S., Triaca, V., and Lieberthal, W. Lysophosphatidic acid: a novel growth and survival factor for renal proximal tubular cells. Am. J. Physiol., 273: F575-F585, 1997.
18. Frankel, A., and Mills, G. B. Peptide and lipid growth factors decrease cis-diamminedichloroplatinum-induced cell death in human cancer cells. Clin. Cancer Res., 2: 1307-1313, 1996.
19. Xu, Y., Gaudette, D. C., Boynton, J. D., Frankel, A., Fang, X. J., Sharma, A., Hurteau, J., Casey, G., Goodbody, A., Mellors, A., Holub, B. J., and Mills, G. B. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. Clin. Cancer Res., 1: 1223-1232, 1995.
20. Xu, Y., Shen, Z., Wiper, D. W., Wu, M., Morton, R. E., Elson, P., Kennedy, A. W., Belinson, J., Markman, M., and Casey, G. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. J. Am. Med. Assoc., 280: 719-723, 1998.
21. Guo, Z., Liliom, K., Fischer, D. J., Bathurst, I. C., Tomei, L. D., Kiefer, M. C., and Tigyi, G. Molecular cloning of a high-affinity receptor for the growth factor-like lipid mediator lysophosphatidic acid from Xenopus oocytes. Proc. Natl. Acad. Sci. USA, 93: 14367-14372, 1996.
22. An, S., Dickens, M. A., Bleu, T., Hallmark, O. G., and Goetzl, E. J. Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid. Biochem. Biophys. Res. Commun., 231: 619-622, 1997.
23. An, S., Bleu, T., Hallmark, O. G., and Goetzl, E. J. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J. Biol. Chem., 273: 7906-7910, 1998.
24. Fukushima, N., Kimura, Y., and Chun, J. A single receptor encoded by vzg-1/1pA1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid. Proc. Natl. Acad. Sci. USA, 95: 6151-6156, 1998.
25. Hecht, J. H., Weiner, J. A., Post, S. R., and Chun, J. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J. Cell Biol., 135: 1071-1083, 1996.
26. Andrews, P. A., Velury, S., Mann, S. C., and Howell, S. B. cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res., 48: 68-73, 1988.
27. Mann, S. C., Andrews, P. A., and Howell, S. B. Comparison of lipid content, surface membrane fluidity, and temperature dependence of cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. Anticancer Res., 8: 1211-1215, 1988.
28. Louie, K. G., Behrens, B. C., Kinsella, T. J., Hamilton, T. C., Grotzinger, K. R., McKoy, W. M., Winker, M. A., and Ozols, R. F. Radiation survival parameters of antineoplastic drug-sensitive and -resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine. Cancer Res., 45: 2110-2115, 1985.
29. Behrens, B. C., Hamilton, T. C., Masuda, H., Grotzinger, K. R., Whang-Peng, J., Louie, K. G., Knutsen, T., McKoy, W. M., Young, R. C., and Ozols, R. F. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res., 47: 414-418, 1987.
30. Buick, R. N., Pullano, R., and Trent, J. M. Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res., 45: 3668-3676, 1985.
31. Bacus, S. S., Stancovski, I., Huberman, E., Chin, D., Hurwitz, E., Mills, G. B., Ullrich, A., Sela, M., and Yarden, Y. Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells. Cancer Res., 52: 2580-2589, 1992.
32. Mizushima, S., and Nagata, S. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res., 18: 5322, 1990.
33. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970
34. Hansen, M. B., Nielsen, S. E., and Berg, K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods, 119: 203-210, 1989.
35. Davies, M. A., Lu, Y., Sano, T., Fang, X., Tang, P., LaPushin, R., Koul, D., Bookstein, R., Stokoe, D., Yung, W. K., Mills, G. B., and Steck, P. A. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. Cancer Res., 58: 5285-5290, 1998.
36. Yoshida, M., Khokhar, A. R., and Siddik, Z. H. Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines. Cancer Res., 54: 3468-3473, 1994.
37. Siddik, Z. H., Mims, B., Lozano, G., and Thai, G. Independent pathways of p53 induction by cisplatin and X-rays in a cisplatin- resistant ovarian tumor cell line. Cancer Res., 58: 698-703, 1998.
38. Frisch, S. M., and Francis, H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol., 124: 619-626, 1994.
39. Frisch, S. M., and Ruoslahti, E. Integrins and anoikis. Curr. Opin. Cell Biol., 9: 701-706, 1997.
40. Yawata, A., Adachi, M., Okuda, H., Naishiro, Y., Takamura, T., Hareyama, M., Takayama, S., Reed, J. C., and Imai, K. Prolonged cell survival enhances peritoneal dissemination of gastric cancer cells. Oncogene, 16: 2681-2686, 1998.
41. Zondag, G. C., Postma, F. R., Etten, I. V., Verlaan, I., and Moolenaar, W. H. Sphingosine 1-phosphate signalling through the G-protein-coupled receptor Edg-1. Biochem. J., 330: 605-609, 1998.
42. Westermann, A. M., Havik, E., Postma, F. R., Beijnen, J. H., Dalesio, O., Moolenaar, W. H., and Rodenhuis, S. Malignant effusions contain lysophosphatidic acid (LPA)-like activity. Ann. Oncol., 9: 437- 442, 1998.
43. 2 arrest and DNA double-strand breaks. Cancer Res., 48: 4484-4488, 1988.
44. Shen, Z., Belinson, J., Morton, R. E., and Xu, Y. Phorbol 12-myristate 13-acetate stimulates lysophosphatidic acid secretion from ovarian and cervical cancer cells but not from breast or leukemia cells. Gynecol. Oncol., 71: 364-368, 1998.
45. Eichholtz, T., Jalink, K., Fahrenfort, I., and Moolenaar, W. H. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem. J., 291: 677-680, 1993.
46. Watson, S. P., McConnell, R. T., and Lapetina, E. G. Decanoyl lysophosphatidic acid induces platelet aggregation through an extracellular action: evidence against a second messenger role for lysophosphatyidic acid. Biochem. J., 232: 61-66, 1985.
47. Yoshida, A, and Ueda, H. Activation of Gil by lysophosphatidic acid receptor without ligand in the baculovirus expression system. Biochem. Biophys. Res. Commun., 259: 78-84, 1999.